The effect of traditional Chinese medicine prescription Gushen Antai Pill on the treatment outcome of hormone replacement cycle FETs: a multicenter, double-blind, randomized, placebo-controlled trial

Phase 1

Recruiting

• Conditions: FET's infertile women

• Registration Number: ITMCTR1900002686
• Lead Sponsor: Integrative Medicine Research Centre of Reproduction and Heredity, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 18-40 years;
2. there are two or more high-quality transplantable frozen foetuses;
3. the patients who have received FET in hormone replacement cycle;
4. the past FET history is less than 3 times, the history of abortion is less than 2 times, the history of implant failure is less than 2 times;
5. the patients who have not applied similar drug treatment history, no history of mental illness, no abnormality in liver and kidney function and ECG, and normal chromosome karyotype;
6. the patients agree to the experimental study and sign the informed consent.

Exclusion Criteria

1. BMI >= 30kg / m2;
2. reproductive system development abnormality, chromosome karyotype abnormality of both men and women;
3. patients with major systemic diseases;
4. patients with endometriosis, adenomyosis, hydrosalpinx;
5. patients with endometrial disease;
6. patients with recurrent abortion and repeated planting failure.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical pregnancy rate;Persistent pregnancy rate;Incidence of threatened abortion;